Number of leprosy reactions during treatment: clinical correlations and laboratory diagnosis.

about

Number of leprosy reactions during treatment: clinical correlations and laboratory diagnosis.

Item

http://www.wikidata.org/entity/Q38779807

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Number of leprosy reactions du ...... ions and laboratory diagnosis.

@en

type

Item

label

Number of leprosy reactions du ...... ions and laboratory diagnosis.

@en

prefLabel

Number of leprosy reactions du ...... ions and laboratory diagnosis.

@en

P1476

Number of leprosy reactions du ...... ions and laboratory diagnosis.

@en

P2093

Adeilson Viera da Costa

http://www.w3.org/2001/XMLSchema#string

Ana Carolina Rodrigues da Cunha

http://www.w3.org/2001/XMLSchema#string

Douglas Eulálio Antunes

http://www.w3.org/2001/XMLSchema#string

Gabriela Porto Ferreira

http://www.w3.org/2001/XMLSchema#string

Mariana Vitorino Candeiro Nicchio

http://www.w3.org/2001/XMLSchema#string

Rafaela Resende Gomes

http://www.w3.org/2001/XMLSchema#string

Sergio Araujo

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of clinical, epidemiological and laboratory risk factors for leprosy reactions during and after multidrug therapy.

Leprosy now: epidemiology, progress, challenges, and research gaps.

Comparing the clinical and histological diagnosis of leprosy and leprosy reactions in the INFIR cohort of Indian patients with multibacillary leprosy.

Pitfalls in the cytological classification of borderline leprosy in the Ridley-Jopling scale.

Simple and fast lateral flow test for classification of leprosy patients and identification of contacts with high risk of developing leprosy

Immunohistochemical analysis of cellular infiltrate and gamma interferon, interleukin-12, and inducible nitric oxide synthase expression in leprosy type 1 (reversal) reactions before and during prednisolone treatment.

Alternate-day prednisone therapy. Evaluation of delayed hypersensitivity responses, control of disease and steroid side effects.

P304

741-745

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1590/0037-8682-0440-2015

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Isabela Maria Bernardes Goulart

P577

2016-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28001221

http://www.w3.org/2001/XMLSchema#string

P921

Abïl